Spondyloarthritis in familial Mediterranean fever: a cohort study
- 18 June 2022
- journal article
- research article
- Published by Springer Nature in Rheumatology International
- Vol. 42 (10) , 1729-1739
Abstract
Familial Mediterranean fever (FMF) and spondyloarthritis (SpA) may show several common signs. This study aimed to evaluate the frequency of SpA and its manifestations in FMF, the impact of SpA on FMF, and the associations of non-episodic findings (heel enthesitis, protracted arthritis, and sacroiliitis) with the FMF features. Demographic, clinical, imaging, and genetic data were retrieved from medical records of the patients with adult FMF. To identify patients who met the classification criteria for SpA, data including rheumatologic inquiry were recorded. Patients with SpA and those who did not meet the criteria were compared in terms of FMF features. Regression analyses were performed to determine the factors that were most associated with sacroiliitis, enthesitis, and protracted arthritis. Of the 283 patients with FMF, 74 (26.1%) met the SpA criteria (64 axial, 10 peripheral); and 65 (22.9%) patients had sacroiliitis, 27 (9.5%) protracted arthritis, and 61 (21.6%) heel enthesitis. Patients with SpA were older and had more FMF severity, and heel pain rate than those without; however, genetic features, CRP, resistance to colchicine, and heel enthesitis did not differ. A meaningful number of patients without SpA had also displayed heel enthesitis, protracted arthritis, inflammatory back pain, heel pain, family history of SpA, and elevated CRP. Age was found to be the main predictor of heel enthesitis and protracted arthritis was linked with FMF severity. A significant number of patients with FMF meet the peripheral SpA classification criteria as well as axial SpA. SpA and its shared manifestations with FMF may have an impact on FMF.Keywords
This publication has 45 references indexed in Scilit:
- High prevalence of spondyloarthritis and ankylosing spondylitis among familial Mediterranean fever patients and their first-degree relatives: further evidence for the connectionArthritis Research & Therapy, 2013
- Effects of Anti-Tumor Necrosis Factor Agents for Familial Mediterranean Fever Patients With Chronic Arthritis and/or Sacroiliitis Who Were Resistant to Colchicine TreatmentJCR: Journal of Clinical Rheumatology, 2011
- The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in generalAnnals of the Rheumatic Diseases, 2011
- Chronic inflammation in FMF: markers, risk factors, outcomes and therapyNature Reviews Rheumatology, 2010
- The spectrum of MEFV clinical presentations-is it familial Mediterranean fever only?Rheumatology, 2009
- The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selectionAnnals of the Rheumatic Diseases, 2009
- Horror Autoinflammaticus: The Molecular Pathophysiology of Autoinflammatory DiseaseAnnual Review of Immunology, 2009
- The frequency of sacroiliitis in familial Mediterranean fever and the role of HLA-B27 and MEFV mutations in the development of sacroiliitisClinical Rheumatology, 2008
- Characteristics of patients with adult-onset familial Mediterranean fever in Turkey: analysis of 401 casesInternational Journal Of Clinical Practice, 2004
- The clinical patterns of arthritis in children with familial Mediterranean feverQJM: An International Journal of Medicine, 1997